US Patent 7113821 Tissue electroperforation for enhanced drug delivery

Is a

Patent

Patent attributes

Current Assignee

Johnson & Johnson

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

71138210

Patent Inventor Names

Jonas C. T. Wang0

Stephen J. Wisniewski0

Ying Sun0

Ralph W. Oakeson0

Date of Patent

September 26, 2006

Patent Application Number

096440930

Date Filed

August 23, 2000

Patent Citations Received

‌

US Patent 12127779 Methods, systems, and apparatuses for tissue ablation using a modulated exponential decay pulse

‌

US Patent 11974800 Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds

‌

US Patent 12059197 Blood-brain barrier disruption using reversible or irreversible electroporation

‌

US Patent 12102376 System and method for increasing a target zone for electrical ablation

‌

US Patent 12114911 System and method for ablating a tissue site by electroporation with real-time pulse monitoring

...

Patent Primary Examiner

Nicholas D Lucchesi

Patent abstract

The present invention relates to a method and a device for transporting a molecule through a mammalian barrier membrane of at least one layer of cells comprising the steps of: ablating the membrane with an electric current from a treatment electrode; and utilizing a driving force to move the molecule through the perforated membrane.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 7113821 Tissue electroperforation for enhanced drug delivery

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 7113821 Tissue electroperforation for enhanced drug delivery